Health News Archive - May 09, 2011
HARBIN, China, May 9, 2011 /PRNewswire-Asia-FirstCall/ -- Nutrastar International Inc.
CYPRESS, Calif., May 9, 2011 /PRNewswire/ -- Medison and Samsung Electronics jointly announced a new corporate identity of Samsung Medison.
BEDFORD, Mass., May 9, 2011 /PRNewswire/ -- Hologic, Inc.
PITTSBURGH, May 9, 2011 /PRNewswire/ -- TeleTracking Technologies (www.teletracking.com) today announced the appointment of Valerie Fritz as Vice President of Marketing for their real-time location solution (RTLS) division.
MALVERN, Pa., May 9, 2011 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended March 31, 2011.
SAN DIEGO, May 9, 2011 /PRNewswire/ -- OrexigenÂ® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2011.
NANJING, China, May 9, 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that Shanghai Celgen Bio-Pharmaceutical Co., Ltd.
CHARLOTTE, N.C., May 9, 2011 /PRNewswire/ -- MedCath Corporation (Nasdaq: MDTH), a healthcare provider focused on high acuity healthcare services, today announced operating results for its second fiscal quarter ended March 31, 2011.
CHARLOTTE, N.C., May 9, 2011 /PRNewswire/ -- MedCath Corporation (Nasdaq: MDTH), a healthcare provider focused on high acuity healthcare services, today announced that it has entered into definitive agreements relating to the sale of Arkansas Heart Hospital and Heart Hospital of New Mexico. Arkansas Heart Hospital MedCath Corporation announced today it has entered into a definitive agreement to sell its 70.3% ownership interest and management rights in Arkansas Heart Hospital to AR-MED, LLC pursuant to the terms of an Equity Purchase Agreement dated May 6, 2011 (the "Equity Purchase Agreement").
WALTHAM, Mass., May 9, 2011 /PRNewswire/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) today announced the launch of a comprehensive suite of new free and subscriber-based weight loss web-based tools on the Inherent Health website (www.inherenthealth.com).